<DOC>
	<DOCNO>NCT01176201</DOCNO>
	<brief_summary>This open-label study determine ADME ( Absorption , Disposition , Metabolism Excretion ) 14C label SLV337 single dose oral suspension .</brief_summary>
	<brief_title>14-C ADME ( Absorption , Disposition , Metabolism Excretion ) Study Man</brief_title>
	<detailed_description>The Absorption , Disposition , Metabolism Excretion SLV337 investigate single dose oral suspension 14C-SLV337 .</detailed_description>
	<criteria>Inclusion Criteria BMI 18 28 kg/m2 SBP 90140 DBP 5090 Exclusion Criteria Seizures , Orthostatic hypotension</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>SLV337</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Relative bioavailability</keyword>
	<keyword>ADME</keyword>
</DOC>